CNBC September 29, 2021
Key Points
– Increased interest in the novel technology during the pandemic has driven a lot of capital into the sector, fueling record financings and IPOs.
– The iShares Biotechnology ETF, which tracks the biotech industry’s biggest players, has surged roughly 62% over the last two years.
– The S&P 500 has jumped by about 47% over the same time period.
The ongoing Covid-19 pandemic has made biotech companies the hot new technology sector as investor demand drives record IPOs, a panel of top investors told CNBC on Wednesday.
The biotech sector has drawn a lot of attention over the last two years during the pandemic, primarily because “we generated all the life-saving drugs, vaccines, and therapeutics that literally just...
Today's Sponsors
Today's Sponsor